Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA2N4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,678
Award facts
- Contract value 100% obligated
- $25,677.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $25.7K to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pens on January 14, 2026, with a completion date of January 15, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs supporting military and veteran healthcare systems. The place of performance is located at the company's Conshohocken facility.
This delivery order is a child action under AmerisourceBergen's significant $999.999 billion Indefinite Delivery Contract with DLA Troop Support Medical, which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds the primary $999.999 billion IDC with DLA through December 31, 2031, enabling the supply of a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to military treatment facilities and other federal healthcare institutions worldwide. Zepbound, a diabetes medication, represents one of many specialized pharmaceutical products delivered through this contracting vehicle to support federal medical supply chain requirements.
Quick answers
Who was awarded contract SPE2DR26FA2N4?
SPE2DR26FA2N4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FA2N4 worth?
The government has obligated $25,678 on SPE2DR26FA2N4.
Is contract SPE2DR26FA2N4 an order under another contract?
Yes. SPE2DR26FA2N4 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2N4 competed?
The extent of competition for SPE2DR26FA2N4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award